Morgan, Maxwell R. “Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism”. Science and Technology Law Review 11 (November 3, 2009). Accessed April 23, 2024. https://journals.library.columbia.edu/index.php/stlr/article/view/3846.